Making cancer detection as easy as a pregnancy test
Company is active
Event Year: 2023
Company is active
Event Year: 2023
Cleancard is revolutionizing cancer detection by integrating synthetic biology and artificial intelligence to create a user-friendly experience akin to a pregnancy test. The company's core mission is to deliver laboratory-quality diagnostics directly to the home, empowering individuals with convenient and accessible health monitoring. Cleancard's innovative approach facilitates reliable diagnostics and biomarker tracking through urine samples. Currently, they are focused on developing comprehensive at-home cancer tests that provide results within 30 minutes. Their platform technology is designed for continuous expansion, enabling the detection of a growing range of conditions from a single sample, paving the way for proactive and personalized healthcare.
Cleancard is revolutionizing cancer detection by integrating synthetic biology and artificial intelligence to create a user-friendly experience akin to a pregnancy test. The company's core mission is to deliver laboratory-quality diagnostics directly to the home, empowering individuals with convenient and accessible health monitoring. Cleancard's innovative approach facilitates reliable diagnostics and biomarker tracking through urine samples. Currently, they are focused on developing comprehensive at-home cancer tests that provide results within 30 minutes. Their platform technology is designed for continuous expansion, enabling the detection of a growing range of conditions from a single sample, paving the way for proactive and personalized healthcare.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2023
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2023
Healthcare
Healthcare
Healthcare -> Diagnostics
Healthcare -> Diagnostics
Team size: 16
Hiring: No
Team size: 16
Hiring: No
